pcdna3 her2 plasmid (Addgene inc)
Addgene inc is a verified supplier 
90
Structured Review
Addgene inc
pcdna3 her2 plasmid
Pcdna3 Her2 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3+her2+plasmid/pcDNA3-HER2-DMVF-181-N+(Plasmid+%2387622)/pmc11337831-416-6-8
Average 90 stars, based on 5 article reviews
Pcdna3 Her2 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3+her2+plasmid/pcDNA3-HER2-DMVF-181-N+(Plasmid+%2387622)/pmc11337831-416-6-8
Average 90 stars, based on 5 article reviews
pcdna3 her2 plasmid - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Transfection:Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer Article Snippet: .. SUM190-TDXdR and HCC1954-TDXdR cells transfected with Article Title: Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Article Snippet: For immunoprecipitation 2 mg of protein lysates were immune-precipitated with the required antibodies; immune-complexes were recovered with protein G Sepharose (Roche Diagnostics) and detected by Western blotting. .. SW48 cells were transfected with 5μg of Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer. Article Snippet: .. SUM190‐TDXdR and HCC1954‐TDXdR cells transfected with Plasmid Preparation:Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer Article Snippet: .. SUM190-TDXdR and HCC1954-TDXdR cells transfected with Article Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer Article Snippet: .. To generate a lentiviral construct expressing HER2, the target segment was amplified by PCR using Article Title: Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation Article Snippet: For immunoprecipitation 2 mg of protein lysates were immune-precipitated with the required antibodies; immune-complexes were recovered with protein G Sepharose (Roche Diagnostics) and detected by Western blotting. .. SW48 cells were transfected with 5μg of Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer. Article Snippet: .. SUM190‐TDXdR and HCC1954‐TDXdR cells transfected with Sulforhodamine B Assay:Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer Article Snippet: .. SUM190-TDXdR and HCC1954-TDXdR cells transfected with Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer. Article Snippet: .. SUM190‐TDXdR and HCC1954‐TDXdR cells transfected with Proliferation Assay:Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer Article Snippet: .. SUM190-TDXdR and HCC1954-TDXdR cells transfected with Article Title: The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer. Article Snippet: .. SUM190‐TDXdR and HCC1954‐TDXdR cells transfected with Construct:Article Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer Article Snippet: .. To generate a lentiviral construct expressing HER2, the target segment was amplified by PCR using Expressing:Article Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer Article Snippet: .. To generate a lentiviral construct expressing HER2, the target segment was amplified by PCR using Amplification:Article Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer Article Snippet: .. To generate a lentiviral construct expressing HER2, the target segment was amplified by PCR using Polymerase Chain Reaction:Article Title: Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer Article Snippet: .. To generate a lentiviral construct expressing HER2, the target segment was amplified by PCR using |